EP3380121
ACTRII ANTAGONIST FOR USE IN TREATING EYE DISORDERS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
23.11.2016EP published:
20.12.2023EP application number:
16869255.6
EPO information:
European Patent Register
Max expiry date:
22.11.2036
Title in English:
ACTRII ANTAGONIST FOR USE IN TREATING EYE DISORDERSLanguage of the patent:
English
Timeline
Today
23.11.2016EP application
20.12.2023EP Publication
Owner
Name:
Acceleron Pharma Inc.Address:
128 Sidney Street, Cambridge, MA 02139, US
Inventor
Name:
SHERMAN, Matthew, L.Address:
Newton, MA 02459, US
Name:
ATTIE, Kenneth, M.Address:
Boston, MA 02116, US
Priority
Number:
201562258934 PDate:
23.11.2015Country:
US
Classification
Categories:
A61K 39/395, A61K 38/18, A61P 27/02